Wednesday, August 05, 2020 10:29:55 AM
How do you know this:
FDA wants this to move to Covid-19 phase 3 trials.
So you know more than the FDA or Dr. David Boulware, an expert on infectious disease? The White House asked Dr. Boulware for his advice. He is connected to the WHO and the UNO.
Give it a break, you're barking up the wrong tree. imo
$RVVTF
all imho only.
Bucillamine will not save one single life because IT DOESN'T DO ANYTHING TO THE VIRUS.
FDA wants this to move to Covid-19 phase 3 trials.
So you know more than the FDA or Dr. David Boulware, an expert on infectious disease? The White House asked Dr. Boulware for his advice. He is connected to the WHO and the UNO.
Give it a break, you're barking up the wrong tree. imo
$RVVTF
all imho only.
Recent RVVTF News
- Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures • ACCESS Newswire • 05/20/2026 11:45:00 AM
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
